top of page
MedMira Announces the appointment of Vice President of Commercial Operations
Halifax, Nova Scotia, October 3, 2024  – Today, MedMira Inc. (MedMira) (TSXV: MIR) today announced the appointment of Nicole Crenshaw as...
MedMira
3. Okt. 20243 Min. Lesezeit

Kopie der klinischen Studien mit dem Multiplo® Complete Syphilis (TP/nTP)-Antikörpertest beginnen - ein potenzieller Wendepunkt zur Bewältigung der Syphilis-Gesundheitskrise in Kanada
Halifax, Nova Scotia, 13. August 2024 – Heute gibt MedMira Inc. (MedMira) (TSXV: MIR) bekannt, dass es umfassende klinische Studien für...
MedMira
13. Aug. 20245 Min. Lesezeit
MedMira Announces the Hire of Vice President of Business Development
Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their...
MedMira
30. Apr. 20242 Min. Lesezeit


Innovation made easy
With MedMira's patented RVF Technology, there are a myriad of possibilities: As an example, our latest custom made product for one of our...
MedMira
19. Apr. 20241 Min. Lesezeit

MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
Halifax, Nova Scotia, March 13, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent...
MedMira
13. März 20244 Min. Lesezeit
Corporate Update on Clinical Evaluation of MedMira’s Products
Halifax, Nova Scotia,1 February, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to provide an update on the ongoing review...
MedMira
1. Feb. 20243 Min. Lesezeit
bottom of page